OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44 | -99.9% | 15,814 | +19.1% | 0.00% | -20.0% |
| Q3 2022 | $55,000 | -73.9% | 13,274 | -37.0% | 0.01% | -80.0% |
| Q3 2021 | $211,000 | -37.2% | 21,066 | -11.1% | 0.02% | -26.5% |
| Q2 2021 | $336,000 | -1.8% | 23,702 | +13.8% | 0.03% | -12.8% |
| Q1 2021 | $342,000 | +12.5% | 20,828 | -47.9% | 0.04% | -20.4% |
| Q3 2020 | $304,000 | +192.3% | 39,974 | +90.7% | 0.05% | +145.0% |
| Q1 2020 | $104,000 | +23.8% | 20,960 | -0.6% | 0.02% | +33.3% |
| Q4 2018 | $84,000 | -56.9% | 21,077 | +0.1% | 0.02% | -67.4% |
| Q1 2017 | $195,000 | -34.1% | 21,062 | -40.6% | 0.05% | -41.8% |
| Q4 2016 | $296,000 | – | 35,458 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |